Join us on Whatsapp: +91 7977614821 OR Click here to directly join now!

Sunday, March 13, 2011

Super Religare Laboratories (formerly SRL Ranbaxy), is planning to come up with an IPO of 2.8 crore Equity Shares having a Face Value of Rs.10/- each. Super Religare is one of the leading diagnostics services companies in India. SRL provides service in the field of Laboratory Medicine and Clinical Trials in India as well as in our neighboring Asian countries

The issue shall constitute 35% of the fully diluted post-issue paid up capital of the company. Nomura Financial Advisory & Securities (India) Pvt Ltd, Kotak Mahindra Capital Company Limited and Religare Capital Markets Limited are the Book Running Lead Managers to the issue

Check back Indian IPO Blog for the latest updates on Super Religare Laboratories IPO!


Post a Comment

Indian IPO Blog Feed Subscribers

Enter your email address:

Delivered by FeedBurner

- Disclaimer / Terms of Use
- Privacy Policy

Subscribe via email

Enter your email address:

Delivered by FeedBurner

By visiting or accessing this Blog and any/all of its subdomains, you solemnly declare that you have read, understood and agree to - Disclaimer / Terms of Service
View our - Privacy Policy

Trending IPO News

Blog Archive

Feed Subscribers